Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects
Open Access
- 1 May 1974
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 37 (5) , 593-597
- https://doi.org/10.1136/jnnp.37.5.593
Abstract
Platelet aggregation responses to 5-hydroxytryptamine (5-HT) were measured in plasma from migrainous subjects taking either methysergide maleate or ergotamine tartrate and were found to be reduced. Blood 5-HT levels of subjects free of headache were not affected by these drugs. The results support the hypothesis that methysergide and ergotamine act by occupying 5-HT uptake sites in vessel walls, leaving 5-HT molecules available to occupy receptors concerned with vasoconstriction.Keywords
This publication has 13 references indexed in Scilit:
- 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headacheJournal of Neurology, Neurosurgery & Psychiatry, 1972
- Effects of methysergide on platelets incubated with reserpineBritish Journal of Pharmacology, 1971
- An assessment of platelet aggregation induced by 5-hydroxytryptamineJournal of Clinical Pathology, 1971
- Comparative Trial of Serotonin Antagonists in the Management of MigraineBMJ, 1970
- [Total blood serotonin content in migraine patients during attacks and in the period between attacks].1969
- Effects of 5-Hydroxytryptamine on Platelet AggregationNature, 1968
- TOTAL PLASMA SEROTONIN, 5-HYDROXYINDOLEACETIC ACID AND p-HYDROXY-m-METHOXYMANDELIC ACID EXCRETION IN NORMAL AND MIGRAINOUS SUBJECTSBrain, 1965
- Clinical trial of methysergide and other preparations in the management of migraineJournal of Neurology, Neurosurgery & Psychiatry, 1964
- Estimation of 5-hydroxytryptamine in human bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 1964
- Methysergide for Prevention of HeadacheNew England Journal of Medicine, 1964